Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2012
05/31/2012US20120135008 Methods and compositions for targeting polyubiquitin
05/31/2012US20120134998 Secreted ap2 and methods of inhibiting same
05/31/2012US20120134991 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function
05/31/2012US20120134985 Methods for modulating metabolic and circadian rhythms
05/31/2012US20120134978 Cross-Linking of Superoxide Dismutase Monomers
05/31/2012US20120134976 Oral formulations for counteracting effects of aging
05/31/2012US20120134969 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
05/31/2012US20120134966 Embryonic stem cell specific micrornas promote induced pluripotency
05/31/2012US20120134965 Method for differentiation of stem cells into vascular cells and the induction of angiogenesis using the same
05/31/2012US20120134960 Glycosylated human alpha interferon muteins, method for obtaining them and use
05/31/2012US20120134929 Treatment of macrophage-related disorders
05/31/2012US20120134925 Application and Uses of PRG4 and Therapeutic Modulation Thereof
05/31/2012CA2818601A1 Method of treating neurological conditions with extract of nerium species or thevetia species
05/31/2012CA2816288A1 Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
05/30/2012EP2457923A1 Sterol derivative
05/30/2012EP2457921A2 Aureolic acid derivatives, the method for preparation thereof and the uses thereof
05/30/2012EP2457911A1 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nAChR ligands for the treatment of CNS diseases.
05/30/2012EP2457907A1 Flavagline derivatives as neuroprotective agents
05/30/2012EP2457901A1 Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors
05/30/2012EP2457897A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
05/30/2012EP2457571A1 Combinations of dopamine d2 receptor blockade with norepinephrine reuptake inhibition and with norepinephrine alpha 2 receptor blockade
05/30/2012EP2457569A1 Use of active pharmaceutical compounds for the treatment of central nervous system conditions
05/30/2012EP2457567A1 Agent having neurotrophic factor-like activity
05/30/2012EP2456868A1 Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
05/30/2012EP2456774A1 Fused aminodihydro-oxazine derivatives
05/30/2012EP2456772A2 Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
05/30/2012EP2456771A1 Fused aminodihydropyrimidone derivatives
05/30/2012EP2456765A1 Imidazole derivatives as mglur5 antagonists
05/30/2012EP2456763A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders
05/30/2012EP2456754A1 Acyl guanidine derivatives modulating the hedgehog protein signaling pathway
05/30/2012EP2456750A2 New form of the aminoindan mesylate derivative rasaginline mesylate
05/30/2012EP2456469A1 Oligomer-opioid agonist conjugates
05/30/2012EP2456451A1 Inhibitor of inflammatory conditions
05/30/2012EP2456442A1 1h-quinazoline-2, 4 -diones for use in the treatment of neuronal ceroid lipofuscinosis
05/30/2012EP2456440A1 Quinolinone pde2 inhibitors
05/30/2012EP2456438A2 Use of azabicycloalkyl derivatives or pyrrolidine-2-one derivatives
05/30/2012EP2456437A1 Combinations of curcummoids and mtor inhibitors for the treatment of tauopathies
05/30/2012EP2456434A1 Galantamine amino acid and peptide prodrugs and uses thereof
05/30/2012EP2456433A2 Methods for the preparation and use of aqueous solutions of magnesium valproate hydrate and l-carnitine
05/30/2012EP2456432A1 Methods and compositions to reduce oxidative stress
05/30/2012EP2137146B1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
05/30/2012EP2081946B1 Adenosine derivatives for the treatment of pain
05/30/2012EP2049478B1 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
05/30/2012EP1994939B1 Pharmaceutical composition containing GHRP-6 for preventing and eliminating fibrosis and other pathological deposits in tissue
05/30/2012EP1891002B1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
05/30/2012EP1851209B1 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
05/30/2012EP1702919B1 Novel 2-heteroaryl-substituted benzimidazole derivative
05/30/2012EP1452586B1 Method of inducing differentiation of mesodermal stem cells into nervous system cells
05/30/2012EP1438302B1 New sulfonamide derivatives as d3-receptor ligands
05/30/2012EP1283057B2 Cell proliferation inhibitors
05/30/2012CN202236436U Soporific patch
05/30/2012CN1700920B Phophylactic and therapeutic use of hydroxysteroids
05/30/2012CN1642558B Uses of sapogenins and their derivatives
05/30/2012CN1600327B External pasted medication for curing nervus vascularis headache and perparation method of production
05/30/2012CN102482672A 通过抑制唐氏综合征基因的天然反义转录物治疗唐氏综合征基因相关疾病 By suppressing natural antisense transcripts Down syndrome Down syndrome gene therapy gene-related diseases
05/30/2012CN102482670A 通过抑制'hsp70-相互作用蛋白的c末端'(chip)的天然反义转录物而治疗chip相关疾病 By inhibiting 'hsp70- interacting protein c-terminal' (chip) of natural antisense transcripts and treat chip-related diseases
05/30/2012CN102482292A Modulators of 5-ht receptors and methods of use thereof
05/30/2012CN102482282A 多环化合物的新形式 New forms of polycyclic compounds
05/30/2012CN102482276A 杂环化合物及其用途 Heterocyclic compounds and their use
05/30/2012CN102482272A 情绪障碍治疗剂 Mood disorder therapeutic agents
05/30/2012CN102482271A 焦虑障碍治疗剂 Anxiety disorder therapeutic agents
05/30/2012CN102482266A 环状叠氮基钠通道阻断剂 Cyclic azido sodium channel blockers
05/30/2012CN102482264A 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
05/30/2012CN102482263A 苄基哌啶化合物 Benzylpiperidine compound
05/30/2012CN102482262A 作为pde10a酶抑制剂的新的苯基咪唑衍生物 Phenyl-imidazole derivatives as a new inhibitor pde10a
05/30/2012CN102482259A 作为nk3受体拮抗剂的吡咯烷衍生物 Receptor antagonists as nk3 pyrrolidine derivative
05/30/2012CN102482257A Apoptosis signal-regulating kinase inhibitors
05/30/2012CN102482256A N-取代的环状氨基衍生物 N- substituted cyclic amino derivative
05/30/2012CN102482251A 色酮衍生物、其制备方法及其治疗应用 Chromone derivatives, their preparation and their therapeutic application
05/30/2012CN102482228A 含有内酰胺或苯磺酰胺化合物的药物 Drug-containing lactam or benzenesulfonamide compound
05/30/2012CN102482227A 作为γ分泌酶调节剂的取代的三唑和咪唑衍生物 As the γ-secretase modulators substituted triazole and imidazole derivatives
05/30/2012CN102482221A 作为katii抑制剂的双环和三环化合物 Bicyclic and tricyclic compounds as inhibitors katii
05/30/2012CN102482220A 含氮环酰基胍衍生物 Acyl derivatives of nitrogen-containing cyclic guanidine
05/30/2012CN102481368A Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
05/30/2012CN102481333A Immunity inducer
05/30/2012CN102481292A 4-(1h-咪唑-4-基甲基)吡啶的新型药用盐以及它们的治疗应用 4- (1h- imidazol-4-ylmethyl) pyridine novel pharmaceutically acceptable salts and their therapeutic applications
05/30/2012CN102481291A 用于治疗、减轻症状、缓解、改善和预防认知疾病、障碍或病症的方法 A method for treating, alleviating the symptoms, alleviating, ameliorating and preventing cognitive disease, disorder, or condition
05/30/2012CN102481289A 治疗与蛋白激酶ck2活性有关的疾病的方法 Method of treating a protein kinase related to the activity of the disease ck2
05/30/2012CN102481283A 创伤或损伤后中枢神经系统继发性损伤的预防和治疗 After the injury of the central nervous system trauma or secondary injury prevention and treatment
05/30/2012CN102481265A 保护和治疗神经损伤的方法和组合物 Protection and treatment of nerve damage methods and compositions
05/30/2012CN102477372A 一种安神保健酒 One kind of tranquilizer health wine
05/30/2012CN102477093A 一种热稳定人角质细胞生长因子突变体的制备方法及其应用 A heat-stable human keratinocyte growth factor preparation method and its application mutants
05/30/2012CN102477017A 四氢萘衍生物及其在制备预防和/或治疗乳腺癌骨质疏松症药物中的用途 Tetrahydronaphthalene derivatives and the prevention and / or treatment of osteoporosis, breast cancer in the manufacture of a medicament
05/30/2012CN102477010A 吲哚衍生物及其在制备预防和/或治疗乳腺癌骨质疏松症药物中的用途 Indole derivatives and their preparation for prevention and / or use in the treatment of osteoporosis, breast cancer medicament
05/30/2012CN102475892A Application of anti-sense miRNA (Ribonucleic Acid)-210 to preparation of anti-cancer drug
05/30/2012CN102475871A 高效液相色谱测定解郁丸中柴胡皂苷a和柴胡皂苷d含量的方法 HPLC Jieyuwan in a saikosaponin content and methods saikosaponin d
05/30/2012CN102475870A 高效液相色谱测定解郁丸中姜黄素含量的方法 HPLC method curcumin content in Jieyuwan
05/30/2012CN102475855A 癫痫防治颗粒剂 Epilepsy Prevention granules
05/30/2012CN102475854A 一种戒酒的中药制剂 One kind of drinking herbal preparations
05/30/2012CN102475853A 瘫复康 Paralysis Rehabilitation
05/30/2012CN102475840A 专治失眠特效丸 Effects pill cures insomnia
05/30/2012CN102475831A 神虫雄保健品及其制备方法 God insect male health products and its preparation method
05/30/2012CN102475809A 神经衰弱防治片(丸) Neurasthenia prevention tablets (pills)
05/30/2012CN102475804A 脑血通 Naoxuetong
05/30/2012CN102475803A 睡的香眠甜丸 Sleeping pill sweet incense sleep
05/30/2012CN102475791A 酒毒速解片 Quick release tablets alcohol poisoning
05/30/2012CN102475790A 一种用于通鼻清脑、减轻晕车、打鼾等症状的液体制剂 Liquid formulations for nasal clear brain, relieve motion sickness, snoring and other symptoms
05/30/2012CN102475770A 一种具有镇静安神作用的软胶囊及其制备方法 Soft capsule and its preparation method has a sedative effect
05/30/2012CN102475751A 老年痴呆串假片 Alzheimer's string of fake tablets
05/30/2012CN102475746A 大叶蒟有效组分的制备方法 Betel leaf preparation process large effective component
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 1833